RE: "You did not say it but it was said. This statement seems to say that the Kenyans do understand what is being offered to them. They know the risks, and it is their decision what to do"
Sorry, I was the one that misread your reply.
Yes, the Kenyan officials that are allowing these trials know and understand what is being offered to them and their sick patients. AQLV is offering a much lower cost alternative treatment for HIV infected people that is also much less painful.
To prove this, they have to test it like any other company. Can't wait to see this through and if in fact they can do what they think they can. Time will tell, and I believe they will succeed.
"Unlike traditional drugs, all NatuRx(TM) treatments are information-based and do not rely on chemical interaction with active molecules to function," stated AquaLiv CEO, Craig Hoffman. "The Kenyan authorities recognized that our unique treatment has a negligible toxicity and cannot be misused. It is impossible to overdose. In our first regulatory organization experience with NatuRx(TM), the treatment was acknowledged and understood far easier than we anticipated."
Mr. Hoffman continued, "Even more exciting than this warm welcome is the outcome of an approved registration as an alternative medicine. If approved, we will be able to market and sell NatuRx(TM) HIV/AIDS without further clinical trials. And, approval could be granted in the next 30-60 days. The biggest hurdle in biotech is regulatory approval for sale and ongoing costs of continued clinical trials. This will be a big a win for AquaLiv."
In order to produce valuable data, the company intends to continue with the planned clinical trial even though it may not be needed to sell the treatment in Kenya. Several clinics and physicians were identified to participate in the trial. Required protocol is being discussed and budgets are being established for the various participants.
Everything that is going on is withing Kenyan protocol and no laws have been broken. Very exciting times indeed.
vt.
News 
Market Data 
Discover 
AI
